Cited by 45

Aberrant disgust responses and immune reactivity in cocaine-dependent men.

Ersche, Karen D., Hagan, Cindy C., Smith, Dana G., Abbott, Sanja, Jones, P. Simon, Apergis-Schoute, Annemieke M., Döffinger, Rainer·2014·Biological Psychiatry

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2013.08.004

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cocaine is associated with increased immune reactivity and inflammation in humans and neuroinflammation in animal models.

    “Cocaine is a highly potent and addictive brain stimulant that is associated with increased immune reactivity and inflammation in humans (Fox et al., 2012; Ersche et al., 2014; Levandowski et al., 2016; Moreira et al., 2016; Pianca et al., 2017) and neuroinflammation in animal models (Guo et al., 2015; Periyasamy et al., 2017).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 73

  1. [1]DeBeck K. Kerr T. Li K. Fischer B. Buxton J. Montaner J. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs Can Med Assoc J 181 2009 585 589 19841052 PMC2764753
  2. [2]Garfein R.S. Vlahov D. Galai N. Doherty M.C. Nelson K.E. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses Am J Public Health 86 1996 655 661 8629715 PMC1380472
  3. [3]Gordon R.J. Lowy F.D. Bacterial infections in drug users N Engl J Med 353 2005 1945 1954 16267325
  4. [4]Story A. Bothamley G. Hayward A. Crack cocaine and infectious tuberculosis Emerg Infect Dis 14 2008 1466 1469 18760022 PMC2603115
  5. [5]Wilson T. DeHovitz J.A. STDs, HIV, and crack cocaine: A review Aids Patient Care STDS 11 1997 62 66 11361764
  6. [8]Fischer B. Powis J. Cruz M.F. Rudzinski K. Rehm J. Hepatitis C virus transmission among oral crack users: Viral detection on crack paraphernalia Eur J Gastroent Hepat 20 2008 29 32 18090987
  7. [9]Scheinmann R. Hagan H. Lelutiu-Weinberger C. Stern R. Jarlais D.C.D. Flom P.L. Non-injection drug use and Hepatitis C Virus: A systematic review Drug Alcohol Depen 89 2007 1 12 PMC1892753 17174481
  8. [10]Howe C.J. Fuller C.M. Ompad D.C. Galea S. Koblin B. Thomas D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City Drug Alcohol Depen 79 2005 389 395 16102381
  9. [11]Khan M.R. Berger A. Hemberg J. O’Neill A. Dyer T.P. Smyrk K. Non-injection and injection drug use and STI/HIV risk in the United States: The degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users AIDS Behav 17 2013 1185 1194 22890684 PMC3923515
  10. [12]Roy K. Howie H. Sweeney C. Parry J. Molyneaux P. Goldberg D. Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: A case–control study J Viral Hepat 11 2004 277 282 15117332
  11. [13]Gyarmathy V.A. Neaigus A. Miller M. Friedman S.R. Des Jarlais D.C. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users J Acq Immun Def Synd 30 2002 448 456 12138352
  12. [14]Clark K.H. Wiley C.A. Bradberry C.W. Psychostimulant abuse and neuroinflammation: Emerging evidence of their interconnection Neurotox Res 23 2013 174 188 22714667
  13. [15]Friedman H. Pross S. Klein T.W. Addictive drugs and their relationship with infectious diseases FEMS Immunol Med Mic 47 2006 330 342 16872369
  14. [16]Reece A.S. Clinical implications of addiction related immunosuppression J Infection 56 2008 437 445 18440646
  15. [17]Stefanidou M. Loutsidou A.C. Chasapis C.T. Spiliopoulou C.A. Immunotoxicity of Cocaine and Crack Curr Drug Abuse Rev 4 2011 95 97 21696343
  16. [18]Baldwin G.C. Roth M.D. Tashkin D.P. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS J Neuroimmunol 83 1998 133 138 9610681
  17. [19]Pellegrino T. Bayer B.M. In vivo effects of cocaine on immune cell function J Neuroimmunol 83 1998 139 147 9610682
  18. [20]Halpern J.H. Sholar M.B. Glowacki J. Mello N.K. Mendelson J.H. Siegel A.J. Diminished interleukin-6 response to proinflammatory challenge in men and women after intravenous cocaine administration J Clin Endocrinol Metab 88 2003 1188 1193 12629105
  19. [21]Irwin M.R. Olmos L. Wang M. Valladares E.M. Motivala S.J. Fong T. Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: Autonomic mechanisms J Pharmacol Exp Ther 320 2007 507 515 17068203
  20. [22]Chen Y. Ke Q. Xiao Y.F. Wu G. Kaplan E. Hampton T.G. Cocaine and catecholamines enhance inflammatory cell retention in the coronary circulation of mice by upregulation of adhesion molecules Am J Physiol Heart Circ Physiol 288 2005 2323 2331 15637118
  21. [23]Meng Q. Lima J.A. Lai H. Vlahov D. Celentano D.D. Margolick J.B. Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users Int J Cardiol 88 2003 191 198 12714198
  22. [24]Siegel A.J. Mendelson J.H. Sholar M.B. McDonald J.C. Lewandrowski K.B. Lewandrowski E.L. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen Am J Cardiol 89 2002 1133 1135 11988210
  23. [25]Pacheco-Lopez G. Bermudez-Rattoni F. Brain–immune interactions and the neural basis of disease-avoidant ingestive behaviour Philos Trans R Soc Lond B 366 2011 3389 3405 22042916 PMC3189354
  24. [26]Riether C. Doenlen R. Pacheco-Lopez G. Niemi M.B. Engler A. Engler H. Behavioural conditioning of immune functions: How the central nervous system controls peripheral immune responses by evoking associative learning processes Rev Neuroscience 19 2008 1 17 18561817
  25. [27]Stevenson R.J. Case T.I. Oaten M.J. Proactive strategies to avoid infectious disease Philos Trans R Soc Lond B 366 2011 3361 3363 22042913 PMC3189360
  26. [28]Oaten M. Stevenson R.J. Case T.I. Disgust as a disease-avoidance mechanism Psychol Bull 135 2009 303 321 19254082
  27. [29]Curtis V. de Barra M. Aunger R. Disgust as an adaptive system for disease avoidance behaviour Philos Trans R Soc Lond B 366 2011 389 401 21199843 PMC3013466
  28. [30]Rozin P. Fallon A.E. A perspective on disgust Psychol Rev 94 1987 23 41 3823304
  29. [33]Ader R. Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus Science 215 1982 1534 1536 7063864
  30. [34]Schedlowski M. Pacheco-Lopez G. The learned immune response: Pavlov and beyond Brain Behav Immun 24 2010 176 185 19698779
  31. [35]Schaller M. Miller G.E. Gervais W.M. Yager S. Chen E. Mere visual perception of other people’s disease symptoms facilitates a more aggressive immune response Psychol Sci 21 2010 649 652 20483842
  32. [36]Baumann H. Gauldie J. The acute phase response Immunol Today 15 1994 74 80 7512342
  33. [37]Gabay C. Kushner I. Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454 9971870
  34. [38]Butcher E.C. Williams M. Youngman K. Rott L. Briskin M. Lymphocyte trafficking and regional immunity Frank J.D. Advances in Immunology Vol 72 1999 Academic Press San Diego, CA 209 253 10361577
  35. [40]Sheehan D.V. Lecrubier Y. Sheehan K.H. Amorim P. Janavs J. Weiller E. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 1998 22 33 9881538
  36. [41]First M.B. Spitzer R.L. Gibbon M. Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP) 2002 Biometrics Research, New York State Psychiatric Institute New York
  37. [42]Lovibond P.F. Lovibond S.H. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories Behav Res Ther 33 1995 335 343 7726811
  38. [44]Ersche K.D. Stochl J. Woodward J.M. Fletcher P.C. The skinny on cocaine. Insights into eating behavior and body weight in cocaine-dependent men Appetite 71 2013 75 80 23920064 PMC3863945
  39. [45]Preston K.L. Epstein D.H. Cone E.J. Wtsadik A.T. Huestis M.A. Moolchan E.T. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation J Anal Toxicol 26 2002 393 400 12422991
  40. [46]Fuse S. Molloy M.J. Usherwood E.J. Immune responses against persistent viral infections: Possible avenues for immunotherapeutic interventions Crit Rev Immunol 28 2008 159 183 18540829
  41. [47]Black S. Kushner I. Samols D. C-reactive Protein J Biol Chem 279 2004 48487 48490 15337754
  42. [48]Stevenson R.J. Hodgson D. Oaten M.J. Barouei J. Case T.I. The effect of disgust on oral immune function Psychophysiology 48 2011 900 907 21166686
  43. [49]Stevenson R.J. Hodgson D. Oaten M.J. Moussavi M. Langberg R. Case T.I. Disgust elevates core body temperature and up-regulates certain oral immune markers Brain Behav Immun 26 2012 1160 1168 22841694
  44. [50]Szabo S.J. Sullivan B.M. Peng S.L. Glimcher L.H. Molecular mechanisms regulating Th1 immune responses Annual Review of Immunology 21 2003 713 758 12500979
  45. [51]Kobayashi Y. The role of chemokines in neutrophil biology Front Biosci Landmark 13 2008 2400 2407 17981721
  46. [53]Stevenson R.J. Case T.I. Hodgson D. Porzig-Drummond R. Barouei J. Oaten M.J. A scale for measuring hygiene behavior: Development, reliability and validity Am J Infect Control 37 2009 557 564 19362392
  47. [55]Stanislaw H. Todorov N. Calculation of signal detection theory measures Behav Res Meth Instr 31 1999 137 149 10495845
  48. [56]Howell D.C. Statistical Methods for Psychology 4th ed. 1997 Duxbury Press London
  49. [57]Ansar W. Ghosh S. C-reactive protein and the biology of disease Immunol Res 56 2013 131 142 23371836
  50. [58]Hou R. Baldwin D.S. A neuroimmunological perspective on anxiety disorders Hum Psychopharmacol Clin Exp 27 2012 6 14 22213434
  51. [60]Miller G.A. Chapman J.P. Misunderstanding analysis of covariance J Abnorm Psychol 110 2001 40 48 11261398
  52. [61]Critchley H.D. Electrodermal responses: What happens in the brain Neuroscientist 8 2002 132 142 11954558
  53. [62]Erta M. Quintana A. Hidalgo J. Interleukin-6, a major cytokine in the central nervous system Int J Biol Sci 8 2012 1254 1266 23136554 PMC3491449
  54. [63]Lekander M. Furst C.J. Rotstein S. Blomgren H. Fredrikson M. Anticipatory immune changes in women treated with chemotherapy for ovarian-cancer Int J Behav Med 2 1995 1 12 16250785
  55. [65]Stockhorst U. Spennes-Saleh S. Körholz D. Göbel U. Schneider M.E. Steingrüber H.J. Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: Features of a classically conditioned response? Brain Behav Immun 14 2000 198 218 10970680
  56. [66]Aps J.K.M. Martens L.C. Review: The physiology of saliva and transfer of drugs into saliva Forensic Sci Int 150 2005 119 131 15944052
  57. [67]Gornikiewicz A. Sautner T. Brostjan C. Schmierer B. Fugger R. Roth E. Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells FASEB J 14 2000 1093 1100 10834930
  58. [68]Marz P. Cheng J.G. Gadient R.A. Patterson P.H. Stoyan T. Otten U. Sympathetic neurons can produce and respond to interleukin 6 PNAS 95 1998 3251 3256 9501249 PMC19728
  59. [69]Lang P.J. Greenwald M.K. Bradley M.M. Hamm A.O. Looking at Pictures—Affective, facial, visceral, and behavioral reactions Psychophysiology 30 1993 261 273 8497555
  60. [71]Jacobsen T.N. Grayburn P.A. Snyder R.W. Hansen J. Chavoshan B. Landau C. Effects of intranasal cocaine on sympathetic nerve discharge in humans J Clin Invest 99 1997 628 634 9045864 PMC507844
  61. [72]Vongpatanasin W. Mansour Y. Chavoshan B. Arbique D. Victor R.G. Cocaine stimulates the human cardiovascular system via a central mechanism of action Circulation 100 1999 497 502 10430763
  62. [74]Marsland A.L. Bachen E.A. Cohen S. Rabin B. Manuck S.B. Stress, immune reactivity and susceptibility to infectious disease Physiol Behav 77 2002 711 716 12527024
  63. [75]Bosch J.A. De Geus E.J.C. Veerman E.C.I. Hoogstraten J. Amerongen A.V.N. Innate secretory immunity in response to laboratory stressors that evoke distinct patterns of cardiac autonomic activity Psychosom Med 65 2003 245 258 12651992
  64. [76]Reichenberg A. Kraus T. Haack M. Schuld A. Pollmächer T. Yirmiya R. Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion Psychoneuroendocrinology 27 2002 945 956 12383455
  65. [77]Konsman J.P. Parnet P. Dantzer R. Cytokine-induced sickness behaviour: Mechanisms and implications Trends Neurosci 25 2002 154 159 11852148
  66. [80]Roncero C. Grau-Lopez L. Diaz-Moran S. Miquel L. Martinez-Luna N. Casas M. Evaluation of sleep disorders in drug dependent inpatients Med Clin 138 2012 332 335 22018396
  67. [81]Erickson K.L. Medina E.A. Hubbard N.E. Micronutrients and innate immunity J Infect Dis 182 2000 S5 S10 10944478
  68. [82]Gamaldo C.E. Shaikh A.K. McArthur J.C. The sleep-immunity relationship Neurol Clin 30 2012 1313 1343 23099140
  69. [83]Paulus M.P. Tapert S.F. Schulteis G. The role of interoception and alliesthesia in addiction Pharmacol Biochem Behav 94 2009 1 7 19698739 PMC2753707
  70. [85]Goldstein R.Z. Craig A.D. Bechara A. Garavan H. Childress A.R. Paulus M.P. The neurocircuitry of impaired insight in drug addiction Trends Cogn Sci 13 2009 372 380 19716751 PMC2844118
  71. [86]Verdejo-Garcia A. Clark L. Dunn B.D. The role of interoception in addiction: A critical review Neurosci Biobehav Rev 36 2012 1857 1869 22659642
  72. [87]Ribeiro L.A. Sanchez Z.M. Nappo S.A. Surviving crack: A qualitative study of the strategies and tactics developed by Brazilian users to deal with the risks associated with the drug BMC Public Health 10 2010 672 21050465 PMC3091576
  73. [88]Malchy L.A. Bungay V. Johnson J.L. Buxton J. Do crack smoking practices change with the introduction of safer crack kits? Can J Public Health 102 2011 188 192 21714316 PMC6973889

Cited by

Sorted by citations

Authors
Ersche, K. D., Hagan, C. C., Smith, D. G., Abbott, S., Jones, P. S., Apergis-Schoute, A. M., & Döffinger, R.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2014-01
Volume
75
Issue
2
Pages
140-147
ISSN
0006-3223
Cited by
45
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review